Chronic illnesses, major causes of death/disability, drive demand for cellular pathology in diagnosis, making USA a key market.

NEWARK, DELAWARE, UNITED STATES OF AMERICA, November 27, 2023 /EINPresswire.com/ -- The global cellular pathology market is poised for exponential growth, with projections indicating an impressive expansion at a CAGR of 8.3% from 2023 to 2033. According to industry analysis, the market value is estimated to surge from US$ 35.2 Billion in 2023 to a staggering US$ 78.3 Billion by 2033.

Cellular pathology is a vital branch of medicine that studies organs and tissues, diagnosing illnesses and medical problems. The COVID-19 pandemic replaced traditional histopathology reporting with personal microscopes and connected monitors, leading to opportunities in digital pathology. Technological advances and new information have impacted clinical services, such as radiography and pathology.

Request a Sample copy of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6869

The increase in chronic disorders has led to a need for accurate diagnoses and timely treatment plans. Pathology labs play a crucial role in diagnosing and monitoring chronic diseases, providing valuable insights into cellular and molecular changes. The market for services is growing due to increased demand for diagnostic surgical services, improved turnaround time, and adherence to laboratory accreditation and quality assurance regulations.

In general, the market for cellular pathology is likely to expand more in the coming next years. This market provides people with a cheap and rapid way to diagnose illness.

Key Takeaways from Market Study:

By products & services, services accounted for the significant share in the global cellular pathology market, with a valuation of US$ 15.7 Billion in 2022. Pathology services in high-income countries include clinical and anatomic tests, with central laboratories providing infrastructure and limited testing.

With a valuation of US$ 16.2 Billion in 2022, the disease diagnosis application accounted for a significant portion of the global market. Pathology is important for disease monitoring, identification, and clinical care; non-communicable diseases have an impact on policy.

Hospitals held the prominent end user market share in the global market in 2022, growing rapidly with CAGR of 7.5% in predicted period. Pathology services are provided by central laboratories in hospitals in high-income countries, necessitating the use of integrated networks for shared information and savings.

North America maintained the predominant position in the global market in 2022, with a revenue share of 37.1%. North America faces chronic illnesses, affecting 45% of American population, causing mortality, hospitalization, and quality of life as per International journal of environmental research and public health 2018.

“The pandemic has increased usage and necessity for rapid diagnostics and clinical services like cellular pathology” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Market Competition:

The cellular pathology market is highly competitive, with key players like Anika therapeutics and Seikagaku. These companies are constantly participating conferences, award competition with their products and launching new products. Such initiative help companies to gain a large market share while maintaining their current status.

In March 2023, Sakura Finetek USA introduces Tissue-Tek^® Block Filing Cabinet 2400, ergonomic storage system for identification and imaging systems.

In June 2018, NeoGenomics and PPD integrate pathology, molecular testing, diagnostic development, biomarker discovery, and regulatory approval services for cancer research.

Key Companies Profiled:

Leica Biosystems Nussloch GmbH (Danaher Corporation)
BioGenex
Hologic, Inc.
Epredia
Sakura Finetek
F. Hoffmann-La Roche Ltd.
Merck KGaA
Gestalt Diagnostics
Carl Zeiss AG
Olympus Corporation
Abbott Laboratories Inc.
NeoGenomics Laboratories

Gain Access to Detailed Market Insights: Purchase to Uncover Segment-specific Information, Identify Key Trends, Drivers, and Challenges:
https://www.futuremarketinsights.com/checkout/6869

Key Market Segments Covered in the Cellular Pathology Industry Research:

By Product:

Instruments
Microtomes & Cryostat
Pathology Workstations
Slide Strainers
Tissue Processers
Other Instruments
Consumables
Fixation Solutions and Stains
Glass Slides & Cover Slips
Sample Chambers
Cassettes
Reagents & Antibodies
Probes & Kits
Other Consumables
Services
Cytopathology
Histopathology

By Application:

Disease Diagnosis
Drug Discovery and Development
Therapeutic Research

By End User:

Hospitals
Diagnostic Laboratories
Academic Research Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Authored By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

Compression Products Market Size: The market size is projected to surpass a valuation of US$ 6,492 million by 2034. As per the analysis, the compression product market is likely to exhibit a CAGR of 5.8% through 2034, with a current valuation of US$ 3.673.4 million in 2024.

Chronic Wound Care Market Share: The global market size is expected to rise at a CAGR of 3.8% during the projected period 2023 to 2033. The market value is projected to increase from US$ 17,272.4 million in 2023 to US$ 25,042.5 million by 2033.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Ankush Nikam
Future Market Insights, Inc.
+91 90966 84197
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.